Documentation Centre

The Documentation Centre contains a wealth of images, PowerPoint presentations, and videos from scientists and experts involved in the study of topics related to cardiometabolic risk research. Use them for an upcoming presentation or training session, keep them for future reference, or save them in your Personal Account (Your Page). They are there for you!

Newest additions in the Documentation Centre

July 22, 2008 Webcasts

Waist circumference: Getting it right! by Robert Ross, PhD

By Robert Ross, PhD, Professor, School of Kinesiology and Health Studies, Department of Medicine, Division of Endocrinology and Metabolism, Queen's University, Kingston, ON, Canada [6:14 min.] [22 MB]

July 17, 2008 Webcasts

Post-AHA 2007: Atherogenic dyslipidemia

By The International Chair on Cardiometabolic Risk [13:02 min.] [67 MB]

July 11, 2008 Key publications

Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62

By Currie CJ, Poole CD, Conway P.

July 11, 2008 Key publications

Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008;87:593-9

By Motard-Bélanger A, Charest A, Grenier G et al.

July 11, 2008 Key publications

Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 2008; 87:567-76

By Keogh JB, Brinkworth GD, Noakes M, Belobrajdic DP, Buckley JD, Clifton PM.

July 11, 2008 Key publications

Stress-induced cytokine responses and central adiposity in young women. Int J Obes (Lond) 2008;32:443-50

By Brydon L, Wright CE, O'Donnell K, Zachary I, Wardle J, Steptoe A.

July 11, 2008 Key publications

Tumor necrosis factor-alpha is a marker of familial combined hyperlipidemia, independently of metabolic syndrome. Metabolism 2008; 57:563-8

By Pauciullo P, Gentile M, Marotta G et al.

July 11, 2008 Key publications

Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008; 299:1139-48

By Svetkey LP, Stevens VJ, Brantley PJ et al.

July 11, 2008 Key publications

Energy replacement attenuates the effects of prior moderate exercise on postprandial metabolism in overweight/obese men. Int J Obes (Lond).. 2008;32:481-9

By Burton FL, Malkova D, Caslake MJ, Gill JM.

July 10, 2008 Key publications

Relationships between adipose tissue and cytokine responses to a randomized controlled exercise training intervention. Metabolism 2008;57:577-83

By Huffman KM, Slentz CA, Bales CW, Houmard JA, Kraus WE.

July 10, 2008 Key publications

Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008;28:685-91

By Subramanian S, Han CY, Chiba T et al.

July 10, 2008 Key publications

Associations between physical activity, body fat, and insulin resistance (homeostasis model assessment) in adolescents: the European Youth Heart Study. Am J Clin Nutr 2008;87:586-92

By Rizzo NS, Ruiz JR, Oja L, Veidebaum T, Sjöström M.

July 10, 2008 Key publications

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008;299:1265-76

By Bhattacharyya T, Nicholls SJ, Topol EJ et al.

July 10, 2008 Key publications

The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263:336-52

By James WP.

July 10, 2008 Key publications

Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol 2008;51:1104-9

By Ibanez B, Vilahur G, Cimmino G et al.

July 10, 2008 Key publications

The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab 2008;10:271-8

By Andrikoula M, McDowell IF.

July 09, 2008 Key publications

Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) 2008;68:555-60

By Seo JA, Kim NH, Park SY et al.

July 09, 2008 Key publications

Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 2008;29:800-9

By Clarke R, Emberson JR, Breeze E et al.

July 09, 2008 Key publications

Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations. Int J Obes (Lond) 2008;32:421-8

By Legry V, Cottel D, Ferrières J et al.

July 09, 2008 Key publications

Metabolic syndrome status changes with fitness level change: a retrospective analysis. Metab Syndr Relat Disord 2008;6:8-14

By Maxwell MS, Goslin BR, Gellish RL et al.

July 09, 2008 Key publications

Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008;371:923-31

By Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM.

July 09, 2008 Key publications

Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats. Diabetes Obes Metab 2008;10:301-11

By Larsen PJ, Wulff EM, Gotfredsen CF et al.

July 09, 2008 Key publications

Thiazolidinedione insulin sensitizers and the heart: a tale of two organs? Diabetes Obes Metab 2008;10:312-28

By Buckingham RE, Hanna A.

June 19, 2008 Webcasts

Post-AHA 2007: Lifestyle intervention

By The International Chair on Cardiometabolic Risk [10:31 min.] [36 MB]

June 05, 2008 Webcasts

Post-AHA 2007: What’s new about adipose tissue as an endocrine organ?

By The International Chair on Cardiometabolic Risk [15:04 min.] [52 MB]

June 02, 2008 Webcasts

Post-AHA 2007: Hypertriglyceridemic Waist

By The International Chair on Cardiometabolic Risk [11:29 min.] [39 MB]

May 28, 2008 Key publications

Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis 2008;197:355-62

By Schuster H, Fagerberg B, Edwards S et al.

May 28, 2008 Key publications

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism. J Lipid Res 2008;49:543-9

By Millar JS, Brousseau ME, Diffenderfer MR et al.

May 28, 2008 Key publications

An apolipoprotein A-I mimetic dose-dependently increases the formation of pre{beta}1 HDL in human plasma. J Lipid Res 2008;49:581-7

By Troutt JS, Alborn WE, Mosior MK et al.

May 28, 2008 Key publications

Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008;94(3):e7

By Ahn SG, Lim HS, Joe DY et al.

May 28, 2008 Key publications

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78

By Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M.

May 28, 2008 Key publications

Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice. J Lipid Res 2008;49:572-80

By Nelbach L, Shu X, Konrad RJ, Ryan RO, Forte TM.

May 28, 2008 Key publications

Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ 2008;336:491-5

By Davies MJ, Heller S, Skinner TC et al.

May 28, 2008 Key publications

Relationship of adiponectin to serum paraoxonase 1. Atherosclerosis 2008;197:363-7

By Bajnok L, Csongradi E, Seres I et al.

May 28, 2008 Key publications

Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008;32:268-74

By Cheng KH, Chu CS, Lee KT et al.

May 28, 2008 Key publications

Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91

By Drolet R, Richard C, Sniderman AD et al.

May 28, 2008 Key publications

Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008;32:381-7

By Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V.

May 28, 2008 Key publications

Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008;31:562-8

By Musso G, Gambino R, Bo S et al.

May 28, 2008 Key publications

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008;29:649-57

By Schnabel R, Messow CM, Lubos E et al.

May 28, 2008 Key publications

Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J 2008;29:594-601

By Abdulla J, Køber L, Abildstrøm SZ, Christensen E, James WP, Torp-Pedersen C.

May 28, 2008 Key publications

Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes. Diabetes Care 2008;31:501-3

By Voorham J, Haaijer-Ruskamp FM, Stolk RP, Wolffenbuttel BH, Denig P; Groningen Initiative to Analyze Type 2 Diabetes Treatment Group

May 28, 2008 Key publications

The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population. Atherosclerosis 2008;197:147-53

By Noto D, Barbagallo CM, Cefalù AB et al.

May 28, 2008 Key publications

Weight fluctuations and risk for metabolic syndrome in an adult cohort. Int J Obes (Lond) 2008 Feb;32:315-21

By Vergnaud AC, Bertrais S, Oppert JM et al.

May 16, 2008 Key publications

Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome. Am Heart J 2008;155:499.e9-16

By Rosenson RS.

May 16, 2008 Key publications

A prospective study of cardiorespiratory fitness and risk of type 2 diabetes in women. Diabetes Care 2008;31:550-5

By Sui X, Hooker SP, Lee IM et al.

May 16, 2008 Key publications

Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort). Am J Cardiol 2008;101:497-501

By Kannel WB, Vasan RS, Keyes MJ, Sullivan LM, Robins SJ.

May 16, 2008 Key publications

Associations between long-term physical activity, waist circumference and weight gain: a 30-year longitudinal twin study. Int J Obes (Lond) 2008;32:353-61

By Waller K, Kaprio J, Kujala UM.

May 16, 2008 Key publications

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis 2008;197:84-94

By de Souza JA, Vindis C, Hansel B et al.

May 16, 2008 Key publications

Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome. Atherosclerosis 2008;197:139-46

By Ooi EM, Barrett PH, Chan DC, Nestel PJ, Watts GF

May 15, 2008 Webcasts

Dr. Cheese and the Potato family – Train-the-trainer

By The International Chair on Cardiometabolic Risk [1:39 min.] [5 MB]

May 14, 2008 Webcasts

Post-AHA 2007: The Pioneers: Jean Vague et Per Björntorp

By The International Chair on Cardiometabolic Risk [9:19 min.] [18 MB]

May 05, 2008 Key publications

Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol Endocrinol Metab 2008; 294:E203-13

By Moro C, Bajpeyi S, Smith SR.

May 05, 2008 Key publications

Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression. Diabetes Obes Metab 2008;10:251-63

By Moore GB, Pickavance LC, Briscoe CP, Clapham JC, Buckingham RE, Wilding JP.

May 05, 2008 Key publications

Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr 2008;87:347-53

By Kratz M, Swarbrick MM, Callahan HS, Matthys CC, Havel PJ, Weigle DS.

May 05, 2008 Key publications

The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab 2008;10:246-50

By Alexander CM, Landsman PB, Grundy SM.

May 05, 2008 Key publications

LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008;371:483-91

By Sandhu MS, Waterworth DM, Debenham SL et al.

May 05, 2008 Key publications

Fat mass accumulation during childhood determines insulin sensitivity in early adulthood. J Clin Endocrinol Metab 2008;93:445-451

By Leunissen RW, Oosterbeek P, Hol LK, Hellingman AA, Stijnen T, Hokken-Koelega AC.

May 05, 2008 Key publications

Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome. J Clin Endocrinol Metab 2008;93:430-7

By Ooi EM, Watts GF, Nestel PJ, Sviridov D, Hoang A, Barrett PH.

May 05, 2008 Key publications

A novel interaction between dietary composition and insulin secretion: effects on weight gain in the Quebec Family Study. Am J Clin Nutr 2008;87:303-9

By Chaput JP, Tremblay A, Rimm EB, Bouchard C, Ludwig DS.

May 05, 2008 Key publications

Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels. Am J Cardiol 2008;101:315-8

By Ai M, Otokozawa S, Asztalos BF et al.

May 05, 2008 Key publications

Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 2008;263:256-73

By Tall AR.

May 01, 2008 Slide Library

A Simplified View of Victor Dzau´s Cardiovascular Continuum by Luis Miguel Ruilope, MD

By Ruilope L.M. [5 slides] [0.3 MB]

April 25, 2008 Webcasts

Post-AHA 2007: Cardiometabolic Risk

By The International Chair on Cardiometabolic Risk [9:06 min.] [31 MB]

April 17, 2008 Slide Library

Plasma Lipid Transport - Role of HDL by Philip Barter, MD

By Barter P. [20 slides] [1 MB]

April 17, 2008 Webcasts

Dr. Cheese and the Potato family – KISS - Keep it simple stupid!

By The International Chair on Cardiometabolic Risk [1:32 min.] [5 MB]

April 08, 2008 Key publications

Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008;117:798-805

By Ohman MK, Shen Y, Obimba CI et al.

April 08, 2008 Key publications

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-53

By D'Agostino RB Sr, Vasan RS, Pencina MJ et al.

April 08, 2008 Key publications

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2008;51:724-30

By Miller M, Cannon CP, Murphy SA et al.

April 08, 2008 Key publications

Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr 2008;87:295-302

By Koska J, Stefan N, Permana PA et al.

April 08, 2008 Key publications

Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004. Arch Intern Med 2008;168:308-14

By Mellen PB, Gao SK, Vitolins MZ, Goff DC Jr.

April 08, 2008 Key publications

Recent trends in the prevalence of coronary disease: a population-based autopsy study of nonnatural deaths. Arch Intern Med 2008; 168:264-70

By Nemetz PN, Roger VL, Ransom JE, Bailey KR, Edwards WD, Leibson CL.

April 08, 2008 Key publications

Dietary quality 1 year after diagnosis of coronary heart disease. J Am Diet Assoc 2008;108:240-6

By Ma Y, Li W, Olendzki BC et al.

April 08, 2008 Key publications

Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. J Clin Endocrinol Metab 2008;93:557-64

By Chan DC, Nguyen MN, Watts GF, Barrett PH.

April 08, 2008 Key publications

Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008; 117:806-15

By Bourlier V, Zakaroff-Girard A, Miranville A et al.

April 04, 2008 Key publications

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol 2008;51:634-42

By van der Steeg WA, Holme I, Boekholdt SM et al.

April 04, 2008 Key publications

Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008;117:605-13

By Rosito GA, Massaro JM, Hoffmann U et al.

April 04, 2008 Key publications

How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation 2008;117:598-604

By Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, Morris RW.

April 04, 2008 Key publications

Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 2008;93:497-503

By Hammer S, van der Meer RW, Lamb HJ et al.

March 28, 2008 Webcasts

Jogging to...cardiometabolic health!

By The International Chair on Cardiometabolic Risk [3:31 min.] [38 MB]

March 19, 2008 Key publications

Breast size and risk of type 2 diabetes mellitus. CMAJ 2008;178:289-95

By Ray JG, Mohllajee AP, van Dam RM, Michels KB.

March 19, 2008 Key publications

25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008;57(2):298-305

By Hyppönen E, Boucher BJ, Berry DJ, Power C.

March 19, 2008 Key publications

Cross-sectional versus prospective associations of sleep duration with changes in relative weight and body fat distribution: the Whitehall II Study. Am J Epidemiol 2008;167(3):321-9

By Stranges S, Cappuccio FP, Kandala NB et al.

March 19, 2008 Key publications

The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality. Eur Heart J 2008;29:204-212

By Pedersen JO, Heitmann BL, Schnohr P, Grønbæk M.

March 19, 2008 Key publications

Increased arterial stiffness in normoglycemic normotensive offspring of type 2 diabetic parents. Hypertension. 2008;51:182-7

By Giannattasio C, Failla M, Capra A et al.

March 19, 2008 Key publications

Dietary intake and the development of the metabolic syndrome. The Atherosclerosis Risk in Communities Study. Circulation 2008;117:754-761

By Lutsey PL, Steffen LM, Stevens J.

March 19, 2008 Key publications

Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity (Silver Spring) 2007;15:2984-93

By Demerath EW, Sun SS, Rogers N et al.

March 19, 2008 Key publications

Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2008;29:213-23

By Wassink AM, van der Graaf Y, Olijhoek JK, Visseren FL; for the SMART Study Group

March 19, 2008 Key publications

Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia 2008;51:309-19

By Jazet IM, Schaart G, Gastaldelli A et al.

March 19, 2008 Key publications

Consumption of hydrogenated versus nonhydrogenated vegetable oils and risk of insulin resistance and the metabolic syndrome among Iranian adult women. Diabetes Care 2008;31:223-6

By Esmaillzadeh A, Azadbakht L.

March 19, 2008 Key publications

Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions. Diabetes Care 2008;31:366-8

By Kantartzis K, Rittig K, Cegan A et al.

March 19, 2008 Key publications

Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J Lipid Res. 2008;49:308-23

By Maclaren R, Cui W, Simard S, Cianflone K.

March 19, 2008 Key publications

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 2008;57:332-9.

By Risérus U, Sprecher D, Johnson T et al.

March 19, 2008 Key publications

High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 2008;57:367-71

By Taksali SE, Caprio S, Dziura J et al.

March 19, 2008 Key publications

Exercise capacity and mortality in black and white men. Circulation 2008;117:614-22

By Kokkinos P, Myers J, Kokkinos JP et al.

March 19, 2008 Key publications

Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo. J Lipid Res 2008;49:386-93

By Hu W, Abe-Dohmae S, Tsujita M et al.

March 19, 2008 Key publications

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117-25

By Cholesterol Treatment Trialists' (CTT) Collaborators, Kearney PM, Blackwell L et al.

March 19, 2008 Key publications

Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial. J Am Coll Cardiol 2008;51:459-65

By Goldenberg I, Benderly M, Goldbourt U; BIP Study Group.

March 19, 2008 Key publications

The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study. Clin Endocrinol (Oxf) 2008 Jan 15 [Epublication ahead of print]

By Lee J, Heng D, Ma S, Chew SK, Hughes K, Tai ES

March 19, 2008 Key publications

ApoB/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol. Atherosclerosis 2008;196:817-22

By Schmidt C, Fagerberg B.

March 19, 2008 Key publications

Postprandial glucose and not triglyceride concentrations are associated with carotid intima media thickness in women with normal glucose metabolism: the Hoorn prandial study. Atherosclerosis 2008;196:712-9

By Alssema M, Schindhelm RK, Dekker JM et al.

March 19, 2008 Key publications

Lipid management to reduce cardiovascular risk: a new strategy is required. Circulation 2008;117:560-8; discussion 568

By Superko HR, King S 3rd.

March 19, 2008 Key publications

Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 2008;31:369-71

By Healy GN, Wijndaele K, Dunstan DW et al.

March 19, 2008 Key publications

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2008;168:207-17

By Wright JT Jr, Harris-Haywood S, Pressel S et al.

March 19, 2008 Key publications

Clinic-based support to help overweight patients with type 2 diabetes increase physical activity and lose weight. Arch Intern Med 2008;168:141-6

By Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, Bock BC.

March 19, 2008 Key publications

Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. JAMA 2008;299:296-307

By Lynch AI, Boerwinkle E, Davis BR et al.

February 28, 2008 Key publications

Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia. Atherosclerosis 2008; 196:262-9

By Bouhali T, Brisson D, St-Pierre J et al.

February 28, 2008 Key publications

Adiponectin, cardiovascular function, and hypertension. Hypertension 2008;51:8-14

By Wang ZV, Scherer PE.

February 28, 2008 Key publications

No effect of a diet with a reduced glycaemic index on satiety, energy intake and body weight in overweight and obese women. Int J Obes (Lond) 2008;32:160-5

By Aston LM, Stokes CS, Jebb SA.

February 28, 2008 Key publications

Relationship of fat distribution with adipokines in human immunodeficiency virus infection. J Clin Endocrinol Metab 2008;93:216-24

By Kosmiski LA, Bacchetti P, Kotler DP et al.

February 28, 2008 Key publications

Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses. J Clin Endocrinol Metab 2008;93:118-24

By Juurinen L, Kotronen A, Granér M, Yki-Järvinen H.